|
|
Volumn 339, Issue , 2009, Pages
|
|
Palivizumab. An example of indication creep.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
MONOCLONAL ANTIBODY;
PALIVIZUMAB;
COST BENEFIT ANALYSIS;
DRUG COST;
HUMAN;
LETTER;
VIRUS INFECTION;
ANTIBODIES, MONOCLONAL;
ANTIVIRAL AGENTS;
COST-BENEFIT ANALYSIS;
DRUG COSTS;
HUMANS;
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;
|
|
EID: 67650742837
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.b2724 Document Type: Letter |
|
Times cited : (5)
|
|
References (0)
|
